| Segment Reporting |
The Company’s segment results were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | October 2, 2026 | | October 3, 2025 | | October 2, 2026 | | October 3, 2025 | | (In thousands) | | Net sales: | | | | | | | Americas | $ | 337,379 | | | $ | 292,729 | | | $ | 941,628 | | | $ | 856,123 | | | EMEA & APAC | 487,142 | | | 435,116 | | | 1,436,117 | | | 1,265,446 | | | $ | 824,521 | | | $ | 727,845 | | | $ | 2,377,745 | | | $ | 2,121,569 | | | Cost of sales: | | | | | | | | | Americas | $ | 198,046 | | | $ | 180,572 | | | $ | 564,458 | | | $ | 522,738 | | | EMEA & APAC | 302,832 | | | 277,973 | | | 907,321 | | | 808,282 | | | $ | 500,878 | | | $ | 458,545 | | | $ | 1,471,779 | | | $ | 1,331,020 | | | Allocated operating expense: | | | | | | | | | Americas | $ | 16,781 | | | $ | 13,878 | | | $ | 45,537 | | | $ | 41,395 | | | EMEA & APAC | 24,232 | | | 23,256 | | | 69,379 | | | 74,415 | | | $ | 41,013 | | | $ | 37,134 | | | $ | 114,916 | | | $ | 115,810 | | | Other operating expense: | | | | | | | Americas | $ | 55,395 | | | $ | 41,024 | | | $ | 144,436 | | | $ | 123,452 | | | EMEA & APAC | 68,218 | | | 51,644 | | | 199,665 | | | 134,392 | | | $ | 123,613 | | | $ | 92,668 | | | $ | 344,101 | | | $ | 257,844 | | Adjusted EBITDA(1): | | | | | | | | | Americas | $ | 67,157 | | | $ | 57,255 | | | $ | 187,197 | | | $ | 168,538 | | | EMEA & APAC | 91,860 | | | 82,243 | | | 259,752 | | | 248,357 | | | $ | 159,017 | | | $ | 139,498 | | | $ | 446,949 | | | $ | 416,895 | | | Depreciation, amortization and other impairment charges: | | | | | | | | | Americas | $ | 25,418 | | | $ | 8,998 | | | $ | 47,025 | | | $ | 25,846 | | | EMEA & APAC | 15,817 | | | 12,887 | | | 45,946 | | | 32,885 | | | $ | 41,235 | | | $ | 21,885 | | | $ | 92,971 | | | $ | 58,731 | | | Capital expenditures: | | | | | | | | | Americas | $ | 8,571 | | | $ | 4,218 | | | $ | 20,190 | | | $ | 12,334 | | | EMEA & APAC | 9,681 | | | 6,962 | | | 29,510 | | | 15,320 | | | $ | 18,252 | | | $ | 11,180 | | | $ | 49,700 | | | $ | 27,654 | |
(1) Adjusted EBITDA is reconciled to Net income from continuing operations in the table that follows. | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | October 2, 2026 | | October 3, 2025 | | October 2, 2026 | | October 3, 2025 | | (In thousands) | | Net income from continuing operations | $ | 42,160 | | | $ | 65,340 | | | $ | 130,352 | | | $ | 207,716 | | | Income tax expense | 13,261 | | | 17,694 | | | 38,073 | | | 56,476 | | | Interest expense and other, net | 36,511 | | | 23,584 | | | 92,711 | | | 61,365 | | | | | | | | | | Restructuring and other related charges(1) | 11,329 | | | 4,347 | | | 39,807 | | | 10,236 | | Acquisition - amortization and other related charges(2) | 39,917 | | | 16,489 | | | 104,019 | | | 47,682 | | | Depreciation and other amortization | 12,683 | | | 12,044 | | | 38,143 | | | 33,420 | | Other(3) | 3,156 | | | — | | | 3,844 | | | — | | | Adjusted EBITDA | $ | 159,017 | | | $ | 139,498 | | | $ | 446,949 | | | $ | 416,895 | |
(1) Includes severance and other termination benefits, including outplacement services, as well as the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets, costs associated with disposing of discontinued products and other costs in connection with the closure and optimization of facilities and product lines. (2) Includes transaction, diligence and integration expenses totaling $8.8 million and $43.9 million for the three and nine months ended October 2, 2026, respectively, and $6.1 million and $20.4 million for the three and nine months ended October 3, 2025, respectively. Additionally, it includes amortization of intangibles and fair value step up on acquired inventories totaling $31.2 million and $60.1 million for the three and nine months ended October 2, 2026, respectively, and $10.3 million and $27.3 million for the three and nine months ended October 3, 2025, respectively. (3) Includes the impact of the Performance Option Awards granted in June and July 2026. These awards were non-cash, one-time, non-recurring grants with a different structure and size than the Company’s annual equity compensation program totaling $2.8 million and $3.5 million for the three and nine months ended October 2, 2026, respectively. Refer to Note 12, “Equity” for further details on these awards.
The Company’s investments in equity method investees and total assets by segment were as follows: | | | | | | | | | | | | | October 2, 2026 | | December 31, 2025 | | (In thousands) | | Investments in equity method investees: | | | Americas | $ | — | | | $ | — | | | EMEA & APAC | 29,632 | | | 29,558 | | | $ | 29,632 | | | $ | 29,558 | | | Total assets: | | | | | Americas | $ | 3,331,990 | | | $ | 1,717,390 | | | EMEA & APAC | 3,163,221 | | | 3,048,704 | | | $ | 6,495,211 | | | $ | 4,766,094 | |
The Company’s property, plant and equipment, net by geography were as follows: | | | | | | | | | | | | | October 2, 2026 | | December 31, 2025 | | (In thousands) | Property, plant and equipment, net(1): | | | | | United States | $ | 75,308 | | | $ | 72,617 | | | Czech Republic | 71,595 | | | 75,028 | | | Germany | 43,705 | | | 48,245 | | | India | 31,233 | | | 31,437 | | | Mexico | 27,142 | | | 23,464 | | | Other foreign countries | 138,553 | | | 131,085 | | | $ | 387,536 | | | $ | 381,876 | |
(1) As the Company does not allocate all long-lived assets, specifically intangible assets, to each individual country, evaluation of long-lived assets in total is impracticable.
|